Latest Articles about SGMO

Dow Extends Australian Collaboration - Analyst Blog

Zacks Equity Research — Tue, 09 Apr 2013 20:11:33 Z

Dow AgroSciences, a wholly-owned subsidiary of The Dow Chemical Company ( DOW ), has expanded its current association with the Department of Primary Industries (DPI) of the State of

Revenues Rise at Shire - Analyst Blog

Zacks Equity Research — Fri, 27 Apr 2012 23:50:23 Z

Shire plc's ( SHPGY ) first quarter 2012 earnings (excluding special items) of $1.48 per American Depositary Share ( ADS ), were 20% above the year-ago earnings. The year-over-year

Shire to Buy Pervasis Therapeutics - Analyst Blog

Zacks Equity Research — Thu, 19 Apr 2012 01:49:24 Z

Shire plc ( SHPGY ) recently entered into an agreement to acquire almost all the assets of Pervasis Therapeutics. As per the terms of the agreement, Shire will make an upfront payment

Big Profits in Microcaps that Measure Up

Josh Levine — Thu, 12 Apr 2012 21:29:54 Z

By Josh Levine Editor, MicroCap Investor It's like the old vaudeville routine: You can call them “microcaps,” or you can call them small caps,” or you can call them "penny

Shire to Buy FerroKin BioSciences - Analyst Blog

Zacks Equity Research — Fri, 23 Mar 2012 01:22:27 Z

Shire plc ( SHPGY ) recently entered into an agreement to acquire FerroKin BioSciences, Inc. As per the terms of the agreement, Shire will make an upfront payment of $100 million and

Shire and Sangamo Cut a Deal - Analyst Blog

Zacks Equity Research — Wed, 08 Feb 2012 00:45:01 Z

Shire plc ( SHPGY ) and Sangamo BioSciences, Inc. ( SGMO ) recently entered into a collaboration and license agreement for the development of products for hemophilia and other

Rebound Candidates: Stocks Near Lows with Short Covering and Institutional Buying

Kapitall — Thu, 10 Nov 2011 06:10:37 Z

(Written by Alexander Crawford. Institutional data sourced from Fidelity, short data sourced from Yahoo! Finance.) Many investors shy away from stocks that have recently underperformed the

Brain Disorders: 3 Biotech Stocks at the Forefront

Kapitall — Thu, 06 Oct 2011 07:43:32 Z

(Written by Alexander Crawford. Data sourced from Finviz.) A new study by the European Brain Council (EBC) found that the cost of mental and neurological disorders in Europe is far outpacing

Stocks Choppy; U.S. Manufacturing Data Show Modest Gains, Greece Weighs

MidnightTrader.com Staff — Mon, 03 Oct 2011 20:41:24 Z

Stocks are down in mid-day trading as investors continue to digest news that the budget approved by Greece's government came up short of austerity targets, while new data showed that U.S.

Mid-Day Update: Stocks Fall as Greece Concerns Outweigh Economic Uptick

MidnightTrader.com Staff — Mon, 03 Oct 2011 20:35:58 Z

Here's where markets stand at mid-day: -NYSE down 21.76 (-0.32%) to 6,769.89 -DJIA down 10.06 (-0.09%) to 10,903.32 -S&P 500 down 3.55 (-0.31%) to 1,127.87 -Nasdaq down 12.56

Sangamo selloff attracts buyers

David Russell — Mon, 03 Oct 2011 19:00:30 Z

Sangamo Biosciences fell hard today, and some traders are stepping in. optionMONSTER's Heat Seeker monitoring system detected unusual call buying in the drug developer, which is down 25

Top list of unusual option activity

David Russell — Mon, 19 Sep 2011 20:37:18 Z

Nearing the halfway mark in today's session, here are the top names showing unusual option activity on tradeMONSTER's LiveAction data system. Goodrich (GR): Option volume 2,303 percent